||School of Natural & Social Sciences
Office: 316 La Kretz Hall (Annenberg
Dr. Sharp obtained her Ph.D. in Biological Chemistry from the University of California, Los Angeles, School of Medicine, and her postdoctoral training in Molecular Biology in the Division of Chemistry at California Institute of Technology, Pasadena. In addition to her teaching and research endeavors at Cal State, LA, Dr. Sharp works with faculty from CSU campuses statewide to enhance CSU biotechnology teaching and research programs. She is a member of the Strategic Planning Council for the California State University Program for Education and Research in Biotechnology (CSUPERB).
The classes Dr. Sharp teaches include Principles of Gene Manipulation, Molecular Diagnostics, From Concept to Market (a survey of the biotech industry), and a graduate level lab in Genetic Engineering. She coordinates programs for graduate and post-baccalaureate students in the Biotechnology Certificate Program, has worked with other faculty to develop offerings and opportunities in bioinformatics, is a campus liaison for the Stem Cell Internship Program and the Master's in Biotechnology. She can also be contacted for information on programs currently being developed to provide training for Clinical Laboratory Scientist generalist license as well as the specialist license for Clinical Genetic Molecular Biologist Scientist. In addition, she provides research training to undergraduate and graduate students in the Department of Biological Sciences.
An important goal in biomedical research is to
pathways and mechanisms that regulate development,
the transition from cell proliferation to cell
system is muscle development or myogenesis. We
currently have two major projects supported by grant
funding from the
National Institutes of Health. The
uses whole animals and molecular studies to test the
generally expressed tumor suppressor transcription
factor p53 or the
muscle-specific transcription factor MyoD must be
completion of myogenesis in vivo. The
uses an ultra-high throughput ChIP-Seq approach to
regulatory mechanisms involved in controlling binding of
MyoD to DNA as
stop dividing and develop into muscle. We aspire to
contribute to the
understanding of the mechanisms that regulate normal
to enable the development of successful medical
approaches to both
developmental disorders and cancer.
Dr. Sharp has had the good fortune to have had many
students in her lab. Some have gone on to complete
degrees. Many are already making their
contributions in industry,
academia, and the health professions.
A role for p53/MyoD redundancy during myogenesis?
Genomic identification of myogenic regulatory
Regulation of expression of the Id2 gene during
Representative Professional Activities
Ph.D. Biological Chemistry 1981
B.A. Zoology 1967
Fall 2010 Schedule
OFFICE HOURS - in